Ignite Creation Date:
2024-05-05 @ 5:30 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00472264
Status:
TERMINATED
Last Update Posted:
2009-07-02
First Post:
2007-05-09
Brief Title:
A Study To Investigate The Ability To Use 18FDG PET Scanning To Monitor The Effectiveness Of New Drugs In COPD Patients
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
An Exploratory Study To Investigate The Reproducibility Of Lung 18Fluoro-Deoxyglucose Positron Emission Tomography In Patients With Chronic Obstructive Airways Disease COPD In The Absence Of Anti-Inflammatory Treatments
Status:
TERMINATED
Status Verified Date:
2009-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Study terminated on Nov 7 2008 as a result of poor recruitment and changes in business priorities The decision was not based on safety concerns
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
It is hypothesised that there is a difference between the uptake of a radioactive substance 18Ffluorodeoxyglucose FDG in the lungs of patients with Chronic Obstructive Pulmonary Disease COPD and healthy volunteers
Detailed Description:
Single site eligible subjects enrolled in order of presentation
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None